ストックスクリーナーアプリを入手
0.70
0.43%
0.003
プレマーケット:
.69
-0.01
-1.43%
前日終値:
$0.697
開ける：
$0.69
24時間の取引高:
194.41K
Relative Volume:
0.20
時価総額：
$10.09M
収益：
-
当期純損益:
$-20.87M
株価収益率:
-0.4396
EPS:
-1.5924
ネットキャッシュフロー:
$-21.21M
1週間 パフォーマンス:
+14.59%
1か月 パフォーマンス:
-87.04%
6か月 パフォーマンス:
-71.77%
1年 パフォーマンス:
-72.22%
1日の値動き範囲:
$0.66
$0.725
1週間の範囲:
$0.5797
$0.79
52週間の値動き範囲:
$0.5201
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Compare CALC vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.70 | 10.04M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc (CALC) 最新ニュース
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteria2025 Price Momentum & Technical Pattern Recognition Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About CalciMedica Inc? - Benzinga
What is CalciMedica Inc.’s book value per shareWeekly Trend Summary & AI Enhanced Trading Signals - mfd.ru
CalciMedica downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
CalciMedica Shares Plunge After Discontinuing Phase II AKI Study - Citeline News & Insights
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt - Investing.com Canada
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Clinical Trials Arena
CalciMedica discontinues AKI trial following safety concerns By Investing.com - Investing.com South Africa
CALC Stock Slumped 76% On Wednesday — Here’s Why - Stocktwits
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation By Investing.com - Investing.com Nigeria
CalciMedica Discontinues Trial, Stock Faces Volatility - intellectia.ai
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation - Investing.com
Calcimedica Discontinues Phase 2 Kourage Trial - TradingView
CalciMedica Ends KOURAGE Trial, Extends Cash Runway - TipRanks
Sector Update: Health Care - marketscreener.com
CalciMedica oversold on KOURAGE news, says Oppenheimer - TipRanks
CalciMedica ( CALC) Stock: Stops Phase 2 KOURAGE trial amid Enrollment Criteria Concerns - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Gold Jumps Over 4%; Seagate Shares Gain After Q2 Results - Benzinga
Calcimedica sags on halt of Auxora trial in acute kidney injury - BioWorld MedTech
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - Benzinga
CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial - marketscreener.com
Nasdaq Gains 150 Points; Starbucks Shares Rise After Strong Sales - Benzinga
CalciMedica stock craters as trial stopped over 'safety concern' - Fierce Biotech
CalciMedica tumbles as safety concerns halt trial of kidney injury drug - TradingView
CalciMedica stock plunges after discontinuing kidney injury trial By Investing.com - Investing.com Australia
CalciMedica stock plunges after discontinuing kidney injury trial - Investing.com
CalciMedica Halts Phase 2 KOURAGE Trial After Safety Review - TipRanks
CalciMedica discontinues AKI trial following safety concerns - Investing.com
CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial - TipRanks
CalciMedica Inc Discontinues Phase 2 KOURAGE Trial - TradingView
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PR Newswire
Does CalciMedica Inc have consistent dividend growthSell Signal & Real-Time Market Sentiment Reports - baoquankhu1.vn
Aug Catalysts: Why is Neurocrine Biosciences Inc stock going upPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Why CalciMedica Is A Stock To Watch - Nasdaq
Will CalciMedica Inc benefit from rising consumer demandEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
CalciMedica (NASDAQ:CALC) Upgraded to Sell at Wall Street Zen - Defense World
One new option listing on January 13th - TipRanks
Is MOTMQ stock a good choice for value investorsJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Will EDAG Engineering Group AG (ED4) stock recover faster than industryNew Guidance & Daily Oversold Stock Bounce Ideas - Улправда
Is CalciMedica Inc. stock a top momentum playJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to job market data2025 Market WrapUp & Precise Swing Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to global recession fearsJobs Report & Free Long-Term Investment Growth Plans - Улправда
2026 world cup usa national team qualification veteran players low block defense betting odds explained2025 AllTime Highs & AI Powered Market Entry Strategies - Улправда
Will Progress Software Corporation stock benefit from infrastructure spendingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Investors Hope for Bounce in Meyer Apparel Limited After Selloff2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Is Kennametal Inc. stock resilient to inflationQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда
Kamdhenu Ventures Limited (543747) Quarterly Results Are OutDividend Reinvestment Plans & Free Discover Dynamic Stocks - bollywoodhelpline.com
Calcimedica Inc (CALC) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):